TRU DIAGNOSTICS, INC.
A systems-based epigenomic algorithm (W Function Epigenomic Roadmap) that quantifies dynamic epigenetic marker interactions over time to predict disease progression and treatment response
- Sector
- Medtech
- Total capital
- $395K
- Federal grants
- $395K
- 2 awards · 2025–2026
- Rank in peer group#28 of 45
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 6 pending
Capital timeline
Latest events
- Federal grantDefense · Phase I · Deoxyribonucleic Acid (dna) Methylation Risk Scores For Occupational Exposures In Military Aviation Personnel$75K
- Federal grantHealth and Human S · Phase I · Creation of Dynamic, Non-Stochastic, W Function Informed Methylation Risk Scores (MRS) for Diagnostic/Therapeutic Applications$321K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 45 peers
Line = medianMedtech · Software
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 6- PendingMethod for Predicting Health of a Human SubjectUSPTOApplication 18741311
- PendingMethod Of Determining Percentage Of Immune Cell Types In A Saliva SpecimenUSPTOApplication 17490160
- PendingMethod For Predicting Health Of A Human SubjectUSPTOApplication 63472428
Show all 6 patent records
- Method for Predicting Health of a Human SubjectDec 12, 2024 · Application 18741311Pending
- Method Of Determining Percentage Of Immune Cell Types In A Saliva SpecimenMar 30, 2023 · Application 17490160Pending
- Method For Predicting Health Of A Human SubjectApplication 63472428Pending
- Methods And Systems For Analysis Of Epigenetic Biomarker ProxiesApplication PCTUS2025059059Pending
- Methods And Systems For Analysis Of Epigenetic Biomarker ProxiesApplication 63730690Pending
- Method For Predicting Health Of A Human SubjectApplication PCTUS2024033579Pending
Related companies, and why
- CLEARCAM INCSimilar federal contract value in Medtech · null in contracts
- LOGAN RESEARCHSimilar federal contract value in Medtech · null in contracts
- CREMEDICAL CORPSimilar federal contract value in Medtech · null in contracts
- NEUROLIGN USA, LLCSimilar federal contract value in Medtech · null in contracts
- ELORAC, INC.Similar federal contract value in Medtech · null in contracts
- CELESTIAL ONCOLOGY INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .